Bristol-Myers Squibb 4Q Revenues: $4.3 billion (-4%) 4Q Earnings: $27 million (earnings were $735 million 4Q13) FY Revenues: $15.9 billion (-3%) FY Earnings: $2.0 billion (-22%) Comments: U.S. revenues decreased 8% to $2.1 billion in the quarter. International revenues were flat. Abilify sales were down 25% to $476 million. Baraclude sales were down 17% to $341 million. Reyataz sales were down 17%, and the Sustiva franchise sales were down 5% to $407 million. Global Eliquis sales grew by $2...